Bridgewater Advisors’s Mustang Bio MBIO Stock Holding History

Bridgewater Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-60	Closed	-$121K	–	261
2021 Q3	$121K	Buy	60 +7	+13%	+$15K	0.03%	234
2021 Q2	$133K	Buy	+53	New	+$130K	0.04%	225

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bridgewater Advisors's MBIO Position: Q4 2021 in Review

Bridgewater Advisors sold out of Mustang Bio (MBIO) in Q4 2021, closing a stake of 60 shares — an estimated $121K sold.

Bridgewater Advisors first reported a position in MBIO in Q2 2021 and held it in 2 quarters. The position peaked at $133K in Q2 2021. 83 funds tracked by Wall St. Rank hold MBIO as of Q4 2021.

Bridgewater Advisors reported no remaining Mustang Bio position as of Q4 2021 after selling out during the quarter.
Bridgewater Advisors sold 60 Mustang Bio shares in Q4 2021, an estimated $121K.
Bridgewater Advisors first reported a position in Mustang Bio in Q2 2021 and held it in 2 quarters.
Bridgewater Advisors's Mustang Bio position peaked at $133K in Q2 2021.
83 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2021.

Based on Bridgewater Advisors's 13F filing for Q4 2021, filed 7 Feb 2022.